Pelthos Therapeutics Stock Market Capitalization
| PTHS Stock | 25.40 3.60 12.41% |
Fundamental analysis of Pelthos Therapeutics allows traders to better anticipate movements in Pelthos Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Pelthos Therapeutics Company Market Capitalization Analysis
Pelthos Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Pelthos Therapeutics is about 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 100.0% higher than that of the company.
Pelthos Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pelthos Therapeutics' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pelthos Therapeutics could also be used in its relative valuation, which is a method of valuing Pelthos Therapeutics by comparing valuation metrics of similar companies.Pelthos Therapeutics is currently under evaluation in market capitalization category among its peers.
Pelthos Fundamentals
| EBITDA | (7.17 M) | |||
| Net Income | (7.96 M) | |||
| Total Debt | 2.19 M | |||
| Cash Flow From Operations | (5.79 M) | |||
| Total Asset | 1.37 M | |||
| Retained Earnings | (21.47 M) | |||
| Working Capital | (2.71 M) | |||
| Net Asset | 1.37 M |
About Pelthos Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pelthos Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pelthos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pelthos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pelthos Stock Analysis
When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.